Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
14.72
-0.27 (-1.80%)
At close: May 7, 2026, 4:00 PM EDT
14.63
-0.09 (-0.61%)
After-hours: May 7, 2026, 6:31 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $904.56 million as of May 7, 2026. Its market cap has increased by 84.70% in one year.
Market Cap
904.56M
Enterprise Value
555.06M
1-Year Change
84.70%
Ranking
Category
Stock Price
$14.72
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $904.56M, an increase of 9.06%. That is a compound annual growth rate of 1.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 921.16M | 50.65% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 964.40M |
| ORIC Pharmaceuticals | 962.71M |
| SELLAS Life Sciences Group | 950.34M |
| Annexon | 926.29M |
| Absci | 924.91M |
| ARS Pharmaceuticals | 921.48M |
| LB Pharmaceuticals | 917.62M |
| MeiraGTx Holdings | 916.32M |